OC
LEXX icon

Oakworth Capital’s Lexaria Bioscience LEXX Stock Holding History

Oakworth Capital’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,000
Closed -$4.35K – 849
2025
Q2 		$4.35K Hold
5,000
– – ﹤0.01% 536
2025
Q1 		$8.55K Hold
5,000
– – ﹤0.01% 528
2024
Q4 		$10.5K Hold
5,000
– – ﹤0.01% 504
2024
Q3 		$15.3K Hold
5,000
– – ﹤0.01% 477
2024
Q2 		$13.9K Hold
5,000
– – ﹤0.01% 459
2024
Q1 		$18.1K Buy
+5,000
New +$12.7K ﹤0.01% 419

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Oakworth Capital's LEXX Position: Q3 2025 in Review

Oakworth Capital sold out of Lexaria Bioscience (LEXX) in Q3 2025, closing a stake of 5,000 shares — an estimated $4.35K sold.

Oakworth Capital first reported a position in LEXX in Q1 2024 and held it in 6 quarters. The position peaked at $18.1K in Q1 2024. 25 funds tracked by Wall St. Rank hold LEXX as of Q3 2025.

  • Oakworth Capital reported no remaining Lexaria Bioscience position as of Q3 2025 after selling out during the quarter.
  • Oakworth Capital sold 5,000 Lexaria Bioscience shares in Q3 2025, an estimated $4.35K.
  • Oakworth Capital first reported a position in Lexaria Bioscience in Q1 2024 and held it in 6 quarters.
  • Oakworth Capital's Lexaria Bioscience position peaked at $18.1K in Q1 2024.
  • 25 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q3 2025.

Based on Oakworth Capital's 13F filing for Q3 2025, filed 4 Nov 2025.